– UK, London – Synthomer plc (LON: SYNT) today announced the appointment of Michael Willome to its Board of Directors as Group CEO effective on 1st November 2021, succeeding Calum MacLean, who announced he wished to step down.
“I am delighted to welcome Michael to the Company. He is a high calibre, proven business leader with considerable experience in the global speciality chemicals industry and a strong track record of driving growth and profitability. His appointment follows an extensive search process. The Board is confident that Michael brings with him the right capabilities to help lead Synthomer through the next phase of its development, as we continue to deliver our successful strategy and invest in the future growth of the business.” said Board Chair, Caroline Johnstone.
About Michael Willome
Michael Willome is an established public market CEO with a track record of driving performance through both strong operational management and strategic actions, including M&A. He has a deep understanding of the end markets in which Synthomer operates, with specialty chemicals and broad geographic experience.
From January 2016 to April 2021, Michael Willome was CEO of Conzzeta AG, a global conglomerate listed on the SIX Swiss exchange which comprised five businesses. Under his leadership, through organic growth and acquisitions, the group with 5,200 employees achieved a doubling of EBIT in the four years ended 2019 and an increase in revenues to CHF1.6 billion. In 2020, Michael implemented a fundamental transformation of the Company which included focusing on Bystronic and the successful divestment of all other businesses.
Previously, Michael Willome spent 18 years with Clariant AG, latterly leading its global Industrial & Consumer Specialities division from 2010 to 2015, a business which at the time generated sales of CHF1.5 billion and had some 2,300 employees. This followed 13 years in leadership roles in the Asia Pacific, where he was division head of the region, based in Hong Kong, as well as in Canada and Turkey.
Michael Willome said: “Synthomer is a global differentiated and specialty chemical company with a strong track record of delivery, leading positions in its markets, and a portfolio of innovative and sustainable solutions for its customers. I am delighted to be joining the Company at this exciting time in its development. With OMNOVA now fully integrated, Synthomer is in a strong position to continue to pursue its growth agenda and I look forward to working with the team to build further on its success.”
He is currently a Non-Executive Director of Glaston, listed on NASDAQ Helsinki. Michael, a Swiss national, will relocate to the UK and be based in Synthomer’s head office in London.
For more information: https://www.synthomer.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.